mRNA vaccines and SiRNAs targeting cancer immunotherapy: challenges and opportunities
Abstract RNA-based cancer immunotherapy is promising in oncology, leveraging the immune system’s ability to target and eliminate cancer cells. This strategy primarily utilizes messenger RNA (mRNA) vaccines and small interfering RNA (siRNA) to modulate the immune response, presenting a novel and adap...
Saved in:
| Main Authors: | Zhen Lv, Yuheng Dai |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-07-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-03070-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
mRNA turnover rate limits siRNA and microRNA efficacy
by: Erik Larsson, et al.
Published: (2010-11-01) -
Target mRNA abundance dilutes microRNA and siRNA activity
by: Aaron Arvey, et al.
Published: (2010-04-01) -
Small Interfering RNA (siRNA) in Dyslipidemia: A Systematic Review on Safety and Efficacy of siRNA
by: Alla SSM, et al.
Published: (2025-05-01) -
A systemically deliverable lipid-conjugated siRNA targeting DUX4 as an facioscapulohumeral muscular dystrophy therapeutic
by: Katelyn Daman, et al.
Published: (2025-09-01) -
The biogenesis, regulation and functions of transitive siRNA in plants
by: Tan Huijun, et al.
Published: (2024-09-01)